Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Net Margin (2016 - 2025)

Dare Bioscience (DARE) has disclosed Net Margin for 9 consecutive years, with 162340.76% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Margin fell 15111208.0% year-over-year to 162340.76%, compared with a TTM value of 30538.58% through Sep 2025, up 3177399.0%, and an annual FY2024 reading of 41430.9%, down 4035673.0% over the prior year.
  • Net Margin was 162340.76% for Q3 2025 at Dare Bioscience, down from 18079.54% in the prior quarter.
  • Across five years, Net Margin topped out at 18079.54% in Q2 2025 and bottomed at 162340.76% in Q3 2025.
  • Average Net Margin over 4 years is 26491.15%, with a median of 6034.16% recorded in 2023.
  • Peak annual rise in Net Margin hit 5087866bps in 2025, while the deepest fall reached -15111208bps in 2025.
  • Year by year, Net Margin stood at 3.84% in 2022, then crashed by -7379bps to 279.75% in 2023, then skyrocketed by 3126bps to 8465.75% in 2024, then crashed by -2018bps to 162340.76% in 2025.
  • Business Quant data shows Net Margin for DARE at 162340.76% in Q3 2025, 18079.54% in Q2 2025, and 17927.98% in Q1 2025.